Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes

By sjmartinez • June 2, 2023

Essien UR, Singh B, Swabe G, Johnson AE, Eberly LA, Wadhera RK, Breathett K, Vaduganathan M, Magnani JW. Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes. JAMA Netw Open. 2023 Jun 1;6(6):e2316290. doi: 10.1001/jamanetworkopen.2023.16290. PMID: 37261826.

Tags: General Internal Medicine, Publications, Veterans Administration

The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection on Long-Term Symptoms in the Innovative Support for Patients With SARS-CoV-2 Infections Registry (INSPIRE)

Openshaw JJ, Chen J, Rodriguez R, Gottlieb M, McCullough K, Santangelo M, Hill MJ, Gatling K, Idris AH, McDonald S, Wisk LE, Dyal J, Wang[...]

Clinical and Molecular Characteristics of X-linked Agammaglobulinemia Patients 55 Years or Older

Chin AT, Ochs HD, Kobayashi R, Abolhassani H, Alachkar H, Barmettler S, Baxendale H, Boiling K, Cantanzaro J, Chua I, Coulter T, Cunningham-Rundles C, Elcombe[...]

Impact of lifting school mask mandates on community SARS-CoV-2 cases, hospitalizations, and deaths: a retrospective observational study

Ertem Z, Danesharasteh A, Anand ST, Jackson NJ, Nelson RE, Schechter-Perkins EM, Fisher L, Doron S, Branch-Elliman W. Impact of lifting school mask mandates on[...]